North Capital’s Colgate-Palmolive CL Stock Holding History

North Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$80	–	197
2025 Q3	$80	Buy	+1	New	+$85	﹤0.01%	684

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

North Capital's CL Position: Q4 2025 in Review

North Capital sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 1 share — an estimated $80 sold.

North Capital first reported a position in CL in Q3 2025 and held it in 1 quarter. The position peaked at $80 in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

North Capital reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
North Capital sold 1 Colgate-Palmolive share in Q4 2025, an estimated $80.
North Capital first reported a position in Colgate-Palmolive in Q3 2025 and held it in 1 quarter.
North Capital's Colgate-Palmolive position peaked at $80 in Q3 2025.
1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.